Frontage Laboratories, Inc
Quantitation IL-17A in human serum using Quanterix Simoa
Determination of an Endogenous Biomarker -4β-Hydroxycholesterol in K2EDTA Human Plasma by LC-MS/MS
Quantitation of Myostatin/GDF-8 in Human Serum Using an Enzyme Linked Immunosorbent Assay (ELISA)
Specific Quantitation of Antisense Oligonucleotides in Plasma Using MSD
Incorporation of Microsampling Techniques in Bioanalytical Assays
To apply for these roles, please click on the links below:
Scientist-Analytical Services-CMC
Analyzing biomarkers in drug development
Gene therapy: an interview with Hugh Davis
Outsourcing in the bioanalytical field: an interview with Song Li
How does Frontage stay on the cutting edge of bioanalytical advancements?
The Value Of Robust Exploratory Toxicology Testing Prior To Pivotal GLP Studies White Paper
Coffee Chat: developments in cell and gene therapies
The importance of biomarker discovery and personalized medicine: panel discussion
Biomarker bioanalysis support to drug development and personalized medicine
When the cell is the drug: cell and gene therapy panel discussion
Incorporation of microsampling techniques in bioanalytical assays: DBS and capillary microsampling
Pre-existing antibodies within clinical samples: How does this affect immunogenicity outcomes?
Frontage Laboratories, Inc. Your Drug Development Partner
Frontage Laboratories, Inc. is a contract research organization (CRO) that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals.
Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies.
Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.
We are a CRO providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. We have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients. We are committed to providing rigorous scientific expertise to ensure the highest quality and compliance. We have successfully assisted clients to advance hundreds of molecules through development to commercial launch in global markets.
We benefit greatly from having operations in both North America and China (the two largest markets for CRO services in the world) and are well placed to capture growth opportunities in both markets. Our “Two Continents, One System” approach is integral to our commitment to high quality standards. This approach assures our customers the same quality standards, operating procedures and systems in both China and North America, whilst also providing our customers with a detailed and highly experienced understanding of the regulations and requirements for drug discovery and development in both countries. This approach enables us to be a partner of choice for companies with multinational requirements or companies that need support for parallel submissions with the US FDA and China FDA.
Website: http://www.frontagelab.com/
Email: [email protected]
Telephone: 610-232-0100
Address:
700 Pennsylvania Drive
Exton, Pennsylvania
19341
USA
LinkedIn: https://www.linkedin.com/company/frontage-laboratories-inc